NCT06911840

Brief Summary

Study Purpose: The purpose of this study is to conduct an observational cross-sectional analysis of male factor infertility across diverse regions of India utilizing the Aphrodite Criteria. This novel patient classification system offers a systematic approach to describing and managing male infertility, particularly for hypogonadal males with idiopathic infertility. The study aims to evaluate the current state of male fertility across India and identify any regional variations in male reproductive health and hypogonadism, which may be influenced by environmental, lifestyle, and genetic factors. Study Objective: The primary objective of this study is to conduct an observational cross-sectional analysis of male factor infertility across various regions of India using the Aphrodite Criteria. To reveal the prevalence and determinants of male factor infertility across different regions of India. Hypothesis: We hypothesize that there are significant regional differences in male factor infertility characteristics across India, with variations in sperm quality and testicular function due to diverse environmental, lifestyle, and genetic factors. Additionally, we hypothesize that the application of the Aphrodite Criteria will provide a more detailed classification of male infertility compared to conventional semen analysis and that certain lifestyle factors such as smoking, obesity, and occupational exposures will be associated with poorer sperm quality and testicular function. Study Population: The study population will consist of male patients visiting clinics across different IVF centers in India. The total sample size includes subjects from five groups with the following distribution: 35 subjects in Group I ; 416 subjects in Group II; 270 subjects in Group III; 152 subjects in Group IV; 216 subjects in Group V The total sample size for all groups will be 1,090 subjects.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,090

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Jan 2026Oct 2026

First Submitted

Initial submission to the registry

March 28, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

January 23, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2026

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

March 28, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

Male infertilityAzoospermiaAphrodite criteriaPrevelance

Outcome Measures

Primary Outcomes (1)

  • Prevalence of male infertility across the country

    Overall prevalence of male infertility according to the Aphrodite criteria in India.

    6 months

Secondary Outcomes (2)

  • Prevalence of male infertility across various geographical distribution

    6 months

  • Factors associated with male infertility

    6 months

Study Arms (1)

Group 1

All the male population visiting IVF centre

Other: No Intervention: Observational Cohort

Interventions

No intervention

Group 1

Eligibility Criteria

Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale attending IVF Clinic
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All male visiting IVF clinics across different centres

You may qualify if:

  • All male visiting IVF clinic willingly giving consent for andrological evaluation.

You may not qualify if:

  • NONE

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indira IVF Hospital

Udaipur, Rajasthan, 313001, India

Location

Related Publications (3)

  • Esteves SC, Yarali H, Vuong LN, Carvalho JF, Ozbek IY, Polat M, Le HL, Pham TD, Ho TM. Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients. Front Endocrinol (Lausanne). 2021 Mar 12;12:630550. doi: 10.3389/fendo.2021.630550. eCollection 2021.

  • May WL, Johnson WD. A SAS macro for constructing simultaneous confidence intervals for multinomial proportions. Comput Methods Programs Biomed. 1997 Jul;53(3):153-62. doi: 10.1016/s0169-2607(97)01809-9.

  • Esteves SC, Humaidan P, Ubaldi FM, Alviggi C, Antonio L, Barratt CLR, Behre HM, Jorgensen N, Pacey AA, Simoni M, Santi D. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function. Reprod Biomed Online. 2024 Apr;48(4):103647. doi: 10.1016/j.rbmo.2023.103647. Epub 2023 Oct 29.

MeSH Terms

Conditions

Infertility, MaleAzoospermia

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Central Study Contacts

Vipin Chandra, DGO

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Clinical Lab Operations

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 4, 2025

Study Start

January 23, 2026

Primary Completion (Estimated)

June 23, 2026

Study Completion (Estimated)

October 23, 2026

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The following supporting information will be made available as part of the data sharing plan: Study Protocol Available upon request or publication of study results. Statistical Analysis Plan (SAP) Will be shared with interested parties upon completion of the study. Informed Consent Form (ICF) A copy of the ICF will be available upon request from participating sites. Clinical Study Report (CSR) The final CSR will be shared once the study results are finalized and published. Analytic Code Will be shared alongside the study results for transparency and reproducibility of the findings.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
After publication of the study and on request
Access Criteria
Academic researchers, clinicians, and scientists involved in related fields of study. Regulatory Bodies: Organizations such as ethics committees, health authorities, and regulatory agencies that require access for monitoring and compliance purposes. Collaborators and Partners: Institutions or organizations collaborating on the study, subject to agreements for data sharing and confidentiality. What They Will Be Able to Access: Study Protocol: Complete details regarding the study design, objectives, and methodology. Statistical Analysis Plan (SAP): Full plan for data analysis, statistical methods, and handling of results. Informed Consent Form (ICF): Document outlining the consent process and participant rights, shared with participating researchers and ethics boards. Clinical Study Report (CSR): The final comprehensive report including all study findings, results, and conclusions. Analytic Code: The code used for statistical analysis, available for validation and reproducibility

Locations